Westlake BioPartners Fund II, L.P. — SEC insider filings
SEC reporting owner CIK 1811947. 3 insider filings on record with FilingPulse; latest filed 2026-09-21.
Transaction summary — filings shown
Covers all 3 filings on record, filed 2023-05-11 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,250,000 shares, $22,500,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: purchase of 1,250,000 shares @ $18.00 ($22,500,000) in ACELYRIN, Inc., filed 2023-05-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACELYRIN, Inc. (SLRN) | 10% owner | 1 | 1 leg · 1,250,000 sh · $22,500,000 | — | 4 |
| Latigo Biotherapeutics, Inc. (LTGO) | 10% owner | 1 | — | — | 14 |
| Electra Therapeutics, Inc. (ETRA) | 10% owner | 1 | — | — | — |
Insider filings — Westlake BioPartners Fund II, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 3 | Electra Therapeutics, Inc. (ETRA) jointly with Westlake BioPartners Fund I, L.P., Westlake BioPartners GP I, LLC, Westlake BioPartners GP II, LLC | Holdings only — no transactions reported | EDGAR |
| 2026-08-11 | 4 | Latigo Biotherapeutics, Inc. (LTGO) jointly with Westlake BioPartners Fund I, L.P., Westlake BioPartners GP I, LLC, Westlake BioPartners GP II, LLC, Westlake BioPartners Opportunity Fund I, L.P., Westlake BioPartners Opportunity GP I, LLC | Conversion (C): 938,979 · Conversion (C): 3,547,842 · Conversion (C): 1,027,635 · Conversion (C): 3,464,072 · Conversion (C): 1,484,401 · Conversion (C): 165,519 · +8 more | EDGAR |
| 2023-05-11 | 4 | ACELYRIN, Inc. (SLRN) jointly with Westlake BioPartners GP II, LLC, Harper Sean E | Conversion (C): 8,540,729 · Purchase (P): 1,250,000 @ $18 · Conversion (C): 4,056,795 (derivative) · Conversion (C): 2,445,786 (derivative) · Conversion (C): 2,038,148 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1811947 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs